骨骼化血管提高儿童晚期神经母细胞瘤延期一期手术切除率
- 关键词:
- 神经母细胞瘤/外科学; 血管
- 摘要:
- 目的晚期神经母细胞瘤(III～IV期)风险高,手术切除率低,直接影响治疗和预后。本文探讨提高儿童高风险神经母细胞瘤延期一期手术切除率的方法。方法对22例儿童高风险神经母细胞瘤予术前化疗,肿瘤有所缩小后手术,从正常部位血管-髂血管解剖入手,对腹膜后受肿瘤包裹、侵犯的大血管进行骨骼化处理,手术切除,并对结果进行分析。结果22例中,21例完全切除肿瘤,占95.45%,显著高于文献报道完全切除率,且无严重并发症及围手术期死亡病例。结论通过合适的手术方法,对腹膜后大血管行骨骼化处理,能够显著提高神经母细胞瘤延期一期手术完全切除率,且并发症少。
相似文献/References:
[1].小儿颈部大血管损伤[J].临床小儿外科杂志,2010,9(03):0.
[2]周文武,陈文娟,高纪平,等.婴幼儿肢体缺血预处理及对血管内皮功能的影响[J].临床小儿外科杂志,2008,7(05):1.
[3]杨超,王珊,李长春,等.3D打印技术在儿童腹膜后神经母细胞瘤血管骨骼化手术中的应用价值探讨[J].临床小儿外科杂志,2019,18(05):376.[doi:10.3969/j.issn.1671-6353.2019.05.008]
Yang Chao,Wang Shan,Li Changchun,et al.Application of three-dimensional printing technology in vascular skeletal surgery for children with retroperitoneal neuroblastoma[J].Journal of Clinical Pediatric Surgery,2019,18(05):376.[doi:10.3969/j.issn.1671-6353.2019.05.008]
[4]刘珍银,温哲,刘涛,等.门静脉海绵样变Rex手术后桥血管吻合口狭窄球囊扩张术初步探讨[J].临床小儿外科杂志,2019,18(12):999.[doi:10.3969/j.issn.1671-6353.2019.12.003]
Liu Zhenyin,Wen Zhe,Liu Tao,et al.Clinical application of balloon dilatation for anastomotic stenosis after meso-Rex bypass for cavernous transformation of the portal vein[J].Journal of Clinical Pediatric Surgery,2019,18(05):999.[doi:10.3969/j.issn.1671-6353.2019.12.003]
[5]王焕民.关于神经母细胞瘤外科治疗的几点思考[J].临床小儿外科杂志,2022,21(02):101.[doi:10.3760/ama.j.cn.101785-202202032-001]
Wang Huanmin.Reflections on surgical treatment of neuroblastoma[J].Journal of Clinical Pediatric Surgery,2022,21(05):101.[doi:10.3760/ama.j.cn.101785-202202032-001]
[6]李勇,刘登辉,黎明,等.儿童腹部神经母细胞瘤手术技术探讨[J].临床小儿外科杂志,2022,21(02):104.[doi:10.3760/cma.j.cn.101785-202201025-002]
Li Yong,Liu Denghui,Li Ming,et al.Surgical treatment of neuroblastoma-problems and challenges[J].Journal of Clinical Pediatric Surgery,2022,21(05):104.[doi:10.3760/cma.j.cn.101785-202201025-002]
[7]胡嘉健,孙记航,杨深,等.基于影像学危险因素评价化疗对于减少中高危腹膜后神经母细胞瘤手术并发症的作用研究[J].临床小儿外科杂志,2022,21(02):108.[doi:10.3760/cma.j.cn.101785-201909059-003]
Hu Jiajian,Sun Jihang,Yang Shen,et al.Evaluation of chemotherapy for reducing operative complications of medium and high risk retroperitoneal neuroblastoma based on imaging-defined risk factor[J].Journal of Clinical Pediatric Surgery,2022,21(05):108.[doi:10.3760/cma.j.cn.101785-201909059-003]
[8]刘涛,盛庆丰,刘江斌,等.INSS 4期神经母细胞瘤患儿3年无事件生存率的相关因素分析[J].临床小儿外科杂志,2022,21(02):121.[doi:10.3760/cma.j.cn.101785-202011036-005]
Liu Tao,Sheng Qingfeng,Liu Jiangbing,et al.Risk factors related to 3-year EFS in International Neuroblastoma Staging System stage 4 neuroblastoma patients[J].Journal of Clinical Pediatric Surgery,2022,21(05):121.[doi:10.3760/cma.j.cn.101785-202011036-005]
[9]丁浙玉,王金湖,王棋,等.儿童实体肿瘤合并高血压与心肌肥厚3例诊治分析及文献复习[J].临床小儿外科杂志,2022,21(06):586.[doi:10.3760/cma.j.cn101785-202111043-017]
Ding Zheyu,Wang Jinhu,Wang Qi,et al.Solid Tumor with hypertension and myocardial hypertrophy in children: report of 3 cases and literature review[J].Journal of Clinical Pediatric Surgery,2022,21(05):586.[doi:10.3760/cma.j.cn101785-202111043-017]